Background: Tissue damage due to microbial invasion in CSOM cases causes inflammatory mechanisms related to specific and non-specific immunity. Neutrophil Lymphocyte Ratio (NLR) is an inflammatory marker in CSOM as a prognostic indicator of the disease. Objective: To determine the role of NLR as determinant inflammatory parameters of CSOM in predicting disease prognosis. Methods: Analytical observational study with cross sectional design. Sample collection was conducted December 2022-March 2023. There were safe type dry phase CSOM, safe type active phase and dangerous type. The safe type active phase CSOM and dangerous type were given topical antibiotics for 2 weeks. Complete blood Count were repeated to assess NLR after 2 weeks in all types of CSOM. Data analysis used the Kruskal-Wallis alternative test and Spearman rank correlation. Results: A total of 27 samples involved men (55.6%) and women (44.4%). Based on CSOM type, there were 40.8% of safe type dry phase CSOM, 29.6% safe type active phase and 29.6% dangerous type. The average of NLR value were found significantly different both the beginning (p-value=0.004) and the end (p-value=0.010). Comparison of three types of CSOM in the beginning and the end showed significant decrease (p-value <0.05). Conclusion: NLR could not be used as a prognostic indicator in the three types of CSOM, because it is included in the very weak category.
No takes yet. Share an insight, caveat, or question.
Faradilla et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: